Axcelis Technologies, Inc. designs, manufactures, and services ion implantation and other processing equipment used in the fabrication of semiconductor chips in the United States, Europe, and Asia. The company offers high energy, high current, and medium current implanters for various application requirements. It also provides aftermarket lifecycle products and services, including used tools, spare parts, equipment upgrades, maintenance services, and customer training. It sells its equipment and services to semiconductor chip manufacturers through its direct sales force. The company was founded in 1978 and is headquartered in Beverly, Massachusetts.
IPO Year: 2000
Exchange: NASDAQ
Website: axcelis.com
| Date | Price Target | Rating | Analyst |
|---|---|---|---|
| 4/21/2025 | $50.00 | Buy → Neutral | B. Riley Securities |
| 2/12/2025 | Outperform → Mkt Perform | William Blair | |
| 11/8/2024 | Buy → Hold | The Benchmark Company | |
| 5/3/2024 | $130.00 | Hold → Buy | Craig Hallum |
| 12/15/2023 | Buy → Neutral | BofA Securities | |
| 9/15/2023 | $225.00 | Buy | BofA Securities |
| 8/4/2023 | $140.00 → $175.00 | Buy → Hold | Craig Hallum |
| 6/14/2023 | Buy → Hold | Needham | |
| 6/5/2023 | Outperform | William Blair | |
| 2/28/2023 | $150.00 | Buy | Loop Capital |
B. Riley Securities downgraded Axcelis Tech from Buy to Neutral and set a new price target of $50.00
William Blair downgraded Axcelis Tech from Outperform to Mkt Perform
The Benchmark Company downgraded Axcelis Tech from Buy to Hold
Craig Hallum upgraded Axcelis Tech from Hold to Buy and set a new price target of $130.00
BofA Securities downgraded Axcelis Tech from Buy to Neutral
BofA Securities initiated coverage of Axcelis Tech with a rating of Buy and set a new price target of $225.00
Craig Hallum downgraded Axcelis Tech from Buy to Hold and set a new price target of $175.00 from $140.00 previously
Needham downgraded Axcelis Tech from Buy to Hold
William Blair initiated coverage of Axcelis Tech with a rating of Outperform
Loop Capital initiated coverage of Axcelis Tech with a rating of Buy and set a new price target of $150.00
4 - AXCELIS TECHNOLOGIES INC (0001113232) (Issuer)
4 - AXCELIS TECHNOLOGIES INC (0001113232) (Issuer)
4 - AXCELIS TECHNOLOGIES INC (0001113232) (Issuer)
S-8 - AXCELIS TECHNOLOGIES INC (0001113232) (Filer)
144 - AXCELIS TECHNOLOGIES INC (0001113232) (Subject)
8-K - AXCELIS TECHNOLOGIES INC (0001113232) (Filer)
10-Q - AXCELIS TECHNOLOGIES INC (0001113232) (Filer)
SD - AXCELIS TECHNOLOGIES INC (0001113232) (Filer)
8-K - AXCELIS TECHNOLOGIES INC (0001113232) (Filer)
8-K - AXCELIS TECHNOLOGIES INC (0001113232) (Filer)
DEF 14A - AXCELIS TECHNOLOGIES INC (0001113232) (Filer)
8-K - AXCELIS TECHNOLOGIES INC (0001113232) (Filer)
8-K - AXCELIS TECHNOLOGIES INC (0001113232) (Filer)
The Company Announces Planned Retirement of Doug Lawson, Executive Vice President of Corporate Marketing and Strategy BEVERLY, Mass., June 27, 2024 /PRNewswire/ -- Axcelis Technologies, Inc. (NASDAQ:ACLS), a leading supplier of enabling ion implantation solutions for the semiconductor industry, today named David Ryzhik as Senior Vice President of Investor Relations and Corporate Strategy, assuming responsibility for the role in July 2024. The Company also announced the retirement of Doug Lawson, Executive Vice President of Corporate Marketing and Strategy. Mr. Lawson plans to retire in July 2024 and will remain as a Senior Advisor through July 2025.
BEVERLY, Mass., April 2, 2024 /PRNewswire/ -- Axcelis Technologies, Inc. (NASDAQ:ACLS), a leading supplier of enabling ion implantation solutions for the semiconductor industry, announced today a shipment of the Company's Purion EXE™ SiC high energy implanter as well as a successful Purion H200™ SiC medium energy implanter evaluation closure at leading power device chipmakers located in Japan. The systems will be used for 150mm and 200mm production of silicon carbide power devices supporting automotive, industrial, energy, and other power intensive applications. Greg Redinbo,
SOLANA BEACH, Calif., July 15, 2021 (GLOBE NEWSWIRE) -- ClearPoint Neuro, Inc. (NASDAQ:CLPT) (the "Company"), a global therapy-enabling platform company providing navigation and delivery to the brain, is pleased to announce that Lynnette C. Fallon has been appointed to the Company's Board of Directors effective immediately. Ms. Fallon will also become a member of the Company's Audit Committee. Ms. Fallon is the Executive Vice President, HR/Legal, General Counsel and Secretary of Axcelis Technologies, Inc. (NASDAQ:ACLS), a provider of equipment and service solutions for the semiconductor manufacturing industry, with locations in eight countries. Ms. Fallon has held her current position sin
BEVERLY, Mass., Jan. 12, 2021 /PRNewswire/ -- Axcelis Technologies, Inc. (Nasdaq: ACLS), a leading supplier of enabling ion implantation solutions for the semiconductor industry, today provided updated financial guidance for the fourth quarter of 2020. The Company expects revenue for the fourth quarter of 2020 to be approximately $120 million, above the $110 million prior guidance. Gross margin of approximately 43% is up from the previous gross margin guidance of 41%. As a result, the Company expects earnings per diluted share of approximately $0.32, up from the previous guidance of approximately $0.21. Cash will be greater than $200 million. Strong performance by our CS&I business contr
BEVERLY, Mass., July 17, 2025 /PRNewswire/ -- Axcelis Technologies, Inc. (NASDAQ:ACLS), a leading supplier of enabling ion implantation solutions for the semiconductor industry will release financial results for the second quarter 2025 before the opening of the market on Tuesday, August 5, 2025. The Company will host a call the same day to discuss the results at 8:30 a.m. ET. The call will be available via webcast that can be accessed through the Investors page of Axcelis' website at www.axcelis.com, or by registering as a participant here:https://register-conf.media-server.co
Q1 Highlights: Revenue of $192.6 millionGAAP Gross Margin of 46.1%, and Non-GAAP Gross Margin of 46.4%GAAP Operating Margin of 15.1% and Non-GAAP Operating Margin of 18.3%GAAP Diluted earnings per share of $0.88, and Non-GAAP Diluted earnings per share of $1.04BEVERLY, Mass., May 6, 2025 /PRNewswire/ -- Axcelis Technologies, Inc. (NASDAQ:ACLS) today announced financial results for the first quarter ended March 31, 2025. President and CEO Russell Low commented, "We executed well in the first quarter, delivering strong profitability despite a moderation in customer investments a
BEVERLY, Mass., April 17, 2025 /PRNewswire/ -- Axcelis Technologies, Inc. (NASDAQ:ACLS), a leading supplier of enabling ion implantation solutions for the semiconductor industry will release financial results for the first quarter 2025 before the opening of the market on Tuesday, May 6, 2025. The Company will host a call the same day to discuss the results at 8:30 a.m. ET. The call will be available via webcast that can be accessed through the Investors page of Axcelis' website at www.axcelis.com, or by registering as a participant here: https://register-conf.media-server.com/
Q4 Highlights: Revenue of $252.4 millionOperating Margin of 21.6%Diluted earnings per share of $1.54BEVERLY, Mass., Feb. 10, 2025 /PRNewswire/ -- Axcelis Technologies, Inc. (NASDAQ:ACLS) today announced financial results for the fourth quarter and full year ended December 31, 2024. For the full year 2024, the Company reported revenue of $1.02 billion, compared with $1.13 billion for the full year 2023. Systems revenue for the year was $782.6 million, compared to $883.6 million in 2023. Operating profit was $210.8 million in 2024, compared to $265.8 million in 2023. Net income
BEVERLY, Mass., Jan. 23, 2025 /PRNewswire/ -- Axcelis Technologies, Inc. (NASDAQ:ACLS), a leading supplier of enabling ion implantation solutions for the semiconductor industry will release financial results for the fourth quarter and full year 2024 after market close on Monday, February 10, 2025. The Company will host a call to discuss the results for the fourth quarter and full year 2024 on Tuesday, February 11, 2025, at 8:30 a.m. ET. The call will be available via webcast that can be accessed through the Investors page of Axcelis' website at www.axcelis.com, or by registeri
Revenue of $256.6 millionOperating margin of 18.3% Diluted earnings per share of $1.49BEVERLY, Mass., Nov. 6, 2024 /PRNewswire/ -- Axcelis Technologies, Inc. (NASDAQ:ACLS) today announced financial results for the third quarter ended September 30, 2024. The Company reported third quarter revenue of $256.6 million, compared to $256.5 million for the second quarter of 2024. Gross margin for the quarter was 42.9%, compared to 43.8% in the second quarter. Operating profit for the quarter was $46.9 million, compared to $52.8 million for the second quarter. Net income for the quarter was $48.6 million, or $1.49 per diluted share, compared to $50.9 million, or $1.55 per diluted share in the second
BEVERLY, Mass., Oct. 16, 2024 /PRNewswire/ -- Axcelis Technologies, Inc. (NASDAQ:ACLS), a leading supplier of enabling ion implantation solutions for the semiconductor industry will release financial results for the third quarter 2024 on Wednesday, November 6, 2024, at 4:00 p.m. ET. The Company will host a call to discuss the results for the third quarter 2024 on Thursday, November 7, 2024, at 8:30 a.m. ET. The call will be available via webcast that can be accessed through the Investors page of Axcelis' website at www.axcelis.com, or by registering as a Participant here: https://register.vevent.com/register/BI64036dd04ee74de4bea3e1ba939fae67
Revenue of $256.5 millionOperating margin of 20.6% Diluted earnings per share of $1.55 BEVERLY, Mass., July 31, 2024 /PRNewswire/ -- Axcelis Technologies, Inc. (NASDAQ:ACLS) today announced financial results for the second quarter ended June 30, 2024. The Company reported second quarter revenue of $256.5 million, compared to $252.4 million for the first quarter of 2024. Gross margin for the quarter was 43.8%, compared to 46.0% in the first quarter. Operating profit for the quarter was $52.8 million, compared to $56.5 million for the first quarter. Net income for the quarter was $50.9 million, or $1.55 per diluted share, compared to $51.6 million, or $1.57 per diluted share in the first quart
BEVERLY, Mass., July 17, 2024 /PRNewswire/ -- Axcelis Technologies, Inc. (NASDAQ:ACLS), a leading supplier of enabling ion implantation solutions for the semiconductor industry will release financial results for the second quarter 2024 on Wednesday, July 31, 2024, at 4:00 p.m. ET. The Company will host a call to discuss the results for the second quarter 2024 on Thursday, August 1, 2024, at 8:30 a.m. ET. The call will be available to interested listeners via an audio webcast that can be accessed through the Investors page of Axcelis' website at www.axcelis.com, or by registering as a Participant here: https://register.vevent.com/register/BIc2d772b56d7b46c0a39772ba7468e5a0
Revenue, Gross Margin and EPS Beat Guidance BEVERLY, Mass., May 1, 2024 /PRNewswire/ -- Axcelis Technologies, Inc. (NASDAQ:ACLS) today announced financial results for the first quarter ended March 31, 2024. The Company reported first quarter revenue of $252.4 million, compared to $310.3 million for the fourth quarter of 2023. Gross margin for the quarter was 46%, compared to 44.4% in the fourth quarter. Operating profit for the quarter was $56.5 million, compared to $79.1 million for the fourth quarter. Net income for the quarter was $51.6 million, or $1.57 per diluted share,
4 - AXCELIS TECHNOLOGIES INC (0001113232) (Issuer)
4 - AXCELIS TECHNOLOGIES INC (0001113232) (Issuer)
4 - AXCELIS TECHNOLOGIES INC (0001113232) (Issuer)
4 - AXCELIS TECHNOLOGIES INC (0001113232) (Issuer)
4 - AXCELIS TECHNOLOGIES INC (0001113232) (Issuer)
4 - AXCELIS TECHNOLOGIES INC (0001113232) (Issuer)
4 - AXCELIS TECHNOLOGIES INC (0001113232) (Issuer)
4 - AXCELIS TECHNOLOGIES INC (0001113232) (Issuer)
4 - AXCELIS TECHNOLOGIES INC (0001113232) (Issuer)
4 - AXCELIS TECHNOLOGIES INC (0001113232) (Issuer)
BEVERLY, Mass., July 29, 2025 /PRNewswire/ -- Axcelis Technologies, Inc. (NASDAQ:ACLS), a leading supplier of enabling ion implantation solutions for the semiconductor industry, announced the company's plans to participate in the following upcoming investor conferences in August: The KBCM Technology Leadership Forum on Monday, August 11th at the Montage Deer Valley, Park City, UT.The Jefferies Semiconductor, IT Hardware and Communications Technology Conference on Tuesday, August 26th at the Four Seasons Hotel, Chicago, IL.The Evercore ISI 2025 Semiconductor, IT Hardware & Netw
BEVERLY, Mass., July 17, 2025 /PRNewswire/ -- Axcelis Technologies, Inc. (NASDAQ:ACLS), a leading supplier of enabling ion implantation solutions for the semiconductor industry will release financial results for the second quarter 2025 before the opening of the market on Tuesday, August 5, 2025. The Company will host a call the same day to discuss the results at 8:30 a.m. ET. The call will be available via webcast that can be accessed through the Investors page of Axcelis' website at www.axcelis.com, or by registering as a participant here:https://register-conf.media-server.co
BEVERLY, Mass., May 7, 2025 /PRNewswire/ -- Axcelis Technologies, Inc. (NASDAQ:ACLS), a leading supplier of enabling ion implantation solutions for the semiconductor industry, announced the company's plans to participate in the following upcoming investor conferences: The 53rd Annual J.P. Morgan Global Technology, Media and Communications Conference on May 14th at the Westin Boston Seaport District.The 25th Annual B. Riley Investor Conference on Wednesday, May 21st at the Ritz-Carlton, Marina del Rey, CA. The 53rd Annual TD Cowen Technology, Media & Telecom Conference on Wedn
Q1 Highlights: Revenue of $192.6 millionGAAP Gross Margin of 46.1%, and Non-GAAP Gross Margin of 46.4%GAAP Operating Margin of 15.1% and Non-GAAP Operating Margin of 18.3%GAAP Diluted earnings per share of $0.88, and Non-GAAP Diluted earnings per share of $1.04BEVERLY, Mass., May 6, 2025 /PRNewswire/ -- Axcelis Technologies, Inc. (NASDAQ:ACLS) today announced financial results for the first quarter ended March 31, 2025. President and CEO Russell Low commented, "We executed well in the first quarter, delivering strong profitability despite a moderation in customer investments a
BEVERLY, Mass., April 24, 2025 /PRNewswire/ -- Axcelis Technologies, Inc. (NASDAQ:ACLS), a leading supplier of enabling ion implantation solutions for the semiconductor industry, announced today that it will be a sponsor for the Advanced Semiconductor Manufacturing Conference (ASMC) on May 5-8, 2025, at the Hilton Albany, in Albany, New York. This event brings together manufacturers, equipment and materials suppliers, and academia to solve manufacturing challenges with innovative strategies and methodologies. Axcelis will present in Session 5: Contamination Free Manufacturing:
BEVERLY, Mass., April 17, 2025 /PRNewswire/ -- Axcelis Technologies, Inc. (NASDAQ:ACLS), a leading supplier of enabling ion implantation solutions for the semiconductor industry will release financial results for the first quarter 2025 before the opening of the market on Tuesday, May 6, 2025. The Company will host a call the same day to discuss the results at 8:30 a.m. ET. The call will be available via webcast that can be accessed through the Investors page of Axcelis' website at www.axcelis.com, or by registering as a participant here: https://register-conf.media-server.com/
President and CEO Russell Low will Present Keynote Speech at CS Asia BEVERLY, Mass., March 17, 2025 /PRNewswire/ -- Axcelis Technologies, Inc. (NASDAQ:ACLS), a leading supplier of enabling ion implantation solutions for the semiconductor industry, announced today that it will be the Diamond Sponsor for the Compound Semiconductor Asia Conference (CS Asia) 2025. The event is being held in conjunction with SEMICON China 2025 on March 25-27, 2025, at the Kerry Hotel in Pudong, Shanghai. Axcelis' President and CEO, Russell Low, will present an opening Keynote Speech at the event. I
BEVERLY, Mass., March 12, 2025 /PRNewswire/ -- Axcelis Technologies, Inc. (NASDAQ:ACLS) a leading supplier of enabling ion implantation solutions for the semiconductor industry, announced today that its Board of Directors has approved an additional $100 million in share repurchase authorization. This approval brings the current outstanding repurchase authorization to $215 million. "Axcelis has maintained a strong cash position supported by solid execution over the past several years. This increased share repurchase authorization reflects our confidence in the attractive long-t
BEVERLY, Mass., Feb. 18, 2025 /PRNewswire/ -- Axcelis Technologies, Inc. (NASDAQ:ACLS), a leading supplier of enabling ion implantation solutions for the semiconductor industry, announced today the company's plans to participate in the following upcoming investor conferences: The Susquehanna Financial Group Fourteenth Annual Technology Conference, taking place at the Lotte New York Palace Hotel on February 27 and 28, 2025. Axcelis management will host one-on-one and small group meetings on Thursday, February 27th with interested investors. For more information on the conferenc
Q4 Highlights: Revenue of $252.4 millionOperating Margin of 21.6%Diluted earnings per share of $1.54BEVERLY, Mass., Feb. 10, 2025 /PRNewswire/ -- Axcelis Technologies, Inc. (NASDAQ:ACLS) today announced financial results for the fourth quarter and full year ended December 31, 2024. For the full year 2024, the Company reported revenue of $1.02 billion, compared with $1.13 billion for the full year 2023. Systems revenue for the year was $782.6 million, compared to $883.6 million in 2023. Operating profit was $210.8 million in 2024, compared to $265.8 million in 2023. Net income
SC 13G/A - AXCELIS TECHNOLOGIES INC (0001113232) (Subject)
SC 13G/A - AXCELIS TECHNOLOGIES INC (0001113232) (Subject)
SC 13G/A - AXCELIS TECHNOLOGIES INC (0001113232) (Subject)
SC 13G/A - AXCELIS TECHNOLOGIES INC (0001113232) (Subject)
SC 13G/A - AXCELIS TECHNOLOGIES INC (0001113232) (Subject)
SC 13G/A - AXCELIS TECHNOLOGIES INC (0001113232) (Subject)
SC 13G/A - AXCELIS TECHNOLOGIES INC (0001113232) (Subject)
SC 13G/A - AXCELIS TECHNOLOGIES INC (0001113232) (Subject)
SC 13G/A - AXCELIS TECHNOLOGIES INC (0001113232) (Subject)
SC 13G/A - AXCELIS TECHNOLOGIES INC (0001113232) (Subject)